129 related articles for article (PubMed ID: 10701699)
1. Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers.
Lamson MJ; Sabo JP; MacGregor TR; Pav JW; Rowland L; Hawi A; Cappola M; Robinson P
Biopharm Drug Dispos; 1999 Sep; 20(6):285-91. PubMed ID: 10701699
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability of two formulations of nevirapine 200-mg tablets in healthy Chinese male volunteers: a single-dose, randomized-sequence, open-label, two-way crossover study.
Zhu Y; Zhang Q; Yu C; Zou J; Yang X; Hu Y
Clin Ther; 2010 Dec; 32(13):2258-64. PubMed ID: 21316541
[TBL] [Abstract][Full Text] [Related]
3. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
Monif T; Rao Thudi N; Koundinya Tippabhotla S; Khuroo A; Marwah A; Kumar Shrivastav V; Tandon M; Raghuvanshi R; Biswal S
Clin Ther; 2007 Dec; 29(12):2677-84. PubMed ID: 18201583
[TBL] [Abstract][Full Text] [Related]
4. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
Stampfuss J; Kubitza D; Becka M; Mueck W
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence study of two nevirapine tablet formulations in human-immunodeficiency-virus-infected patients.
Tarinas A; Tápanes RD; González D; Ferrer G; Abreu D; Pérez J
Farm Hosp; 2007; 31(3):165-8. PubMed ID: 17941755
[TBL] [Abstract][Full Text] [Related]
6. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
Hatorp V; Oliver S; Su CA
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation.
Kakuda TN; Leopold L; Timmers M; Van De Casteele T; Hillewaert V; Tomaka FL; Hoetelmans RM
Int J Clin Pharmacol Ther; 2014 Sep; 52(9):805-16. PubMed ID: 25109510
[TBL] [Abstract][Full Text] [Related]
9. Nevirapine/lamivudine/stavudine as a combined-formulation tablet: bioequivalence study compared with each component administered concurrently under fasting condition.
Monif T; Tippabhotla SK; Garg M; Singla AK; Vijan T
Int J Clin Pharmacol Ther; 2006 Jun; 44(6):276-83. PubMed ID: 16800100
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study.
Kappelhoff BS; van Leth F; MacGregor TR; Lange J; Beijnen JH; Huitema AD;
Antivir Ther; 2005; 10(1):145-55. PubMed ID: 15751772
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of extended-release nevirapine 400 and 300 mg in HIV-1: a multicenter, open-label study.
Battegay M; Arasteh K; Plettenberg A; Bogner JR; Livrozet JM; Witt MD; Mossdorf E; Yong CL; Zhang W; Macha S; Berger F; Stern J; Robinson P; Quinson AM
Clin Ther; 2011 Sep; 33(9):1308-20. PubMed ID: 21872931
[TBL] [Abstract][Full Text] [Related]
12. Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1.
Dimmitt DC; Choo YS; Martin LA; Arumugham T; Hahne WF; Weir SJ
Biopharm Drug Dispos; 1999 Jan; 20(1):29-39. PubMed ID: 10086835
[TBL] [Abstract][Full Text] [Related]
13. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
[TBL] [Abstract][Full Text] [Related]
14. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
[TBL] [Abstract][Full Text] [Related]
15. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.
Martin PD; Warwick MJ; Dane AL; Brindley C; Short T
Clin Ther; 2003 Oct; 25(10):2553-63. PubMed ID: 14667956
[TBL] [Abstract][Full Text] [Related]
16. A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects.
Narang VS; Lulla A; Malhotra G; Purandare S
J Clin Pharmacol; 2005 Mar; 45(3):265-74. PubMed ID: 15703362
[TBL] [Abstract][Full Text] [Related]
17. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
18. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study.
Kappelhoff BS; Huitema AD; van Leth F; Robinson PA; MacGregor TR; Lange JM; Beijnen JH;
HIV Clin Trials; 2005; 6(5):254-61. PubMed ID: 16306032
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine.
Chokephaibulkit K; Plipat N; Cressey TR; Frederix K; Phongsamart W; Capparelli E; Kolladarungkri T; Vanprapar N
AIDS; 2005 Sep; 19(14):1495-9. PubMed ID: 16135903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
